Skip to Main Content
Services Talent Knowledge
Site Search
Menu

BillBraunlin

He | Him | His

Special Counsel

Overview

Biography

With extensive experience in both science and law, Bill helps clients achieve their business goals by ensuring their innovations are well-protected and strategically positioned in the marketplace. Bill’s patent practice focuses on chemistry, biotechnology, and pharmaceuticals and has included substantial work with battery technologies as well as both large-molecule and small-molecule therapeutics. He offers clients comprehensive services, including patent drafting, prior art searches, patentability analyses, freedom-to-operate assessments, and infringement analyses. Bill has successfully managed large patent portfolios, evaluated technologies for out-licensing, and played a pivotal role in bringing innovations to market. He also provides expert witness services for IPR litigation, drawing on his deep technical background and practical industry experience to support clients in protecting their intellectual property.

Bill brings a wealth of experience from both the academic and industry sectors, with a strong background in molecular biophysics and a PhD in polymer physical chemistry, to his practice. In his previous roles in the pharmaceutical and biotechnology industries, Bill directed research teams focused on drug development for renal disease, metabolic syndrome, and mucoprotection. He also has experience with advancing analytical methods for nucleic acid sequence and structure analysis and the development of nucleic acid switches for diagnostic applications.

In addition to his work in industry, Bill served as a tenured faculty member at a major research university, where he led research programs and authored nearly 40 peer-reviewed publications. His success in securing funding for academic and small business research through grants, including collaborations with start-up companies seeking government support, showcases his ability to navigate complex funding landscapes. Bill draws upon his experience as a grant reviewer for NIH, NSF, and international agencies to provide clients with strategic insight regarding their scientific and business development needs.

Languages

  • German
  • Swedish
Experience

Prior Experience

  • Braunlin Patent Law, Patent Attorney
  • Sunstein LLP, Patent Attorney
  • Sunstein LLP, Patent Agent
  • O&R Patent Law, Patent Agent
  • Access Innovation, Chief Scientific Officer
  • Rutgers University, Research Associate Professor
  • Prediqtus, LLC, Chief Scientific Officer
  • Rational Affinity Devices, Chief Scientific Officer
  • Transgenomic, Director of Biophysics Research
  • Genzyme, Principal Scientist
  • University of Nebraska, Department of Chemistry, Associate Professor of Chemistry
  • Polytechnic University, Department of Chemistry, Assistant Professor of Polymer Chemistry
Knowledge

Selected Media

  • Managing Intellectual Property Magazine, "Realising Dreams: New Hire Eyes Start-Up Work at Barclay Damon"

Featured Media

Alerts

NYSDEC Finalizes Regulations to Manage the Endangered and Threatened Species Mitigation Bank Fund

Alerts

NYS Energy Planning Board Releases Draft Energy Plan, Detailing Pathways to Decarbonization While Maintaining System Reliability Through 2040

Alerts

Non-Judicial Collateral Remedies, Part 3 – Strict Foreclosure

Alerts

Court to Weigh Key Privacy Issues in Web Tracking Case Against Cigna

Alerts

Attention Providers! OMIG Adopts 12-Month Review Period for Newly Initiated Compliance Program Reviews Beginning July 1, 2025

Alerts

New York Court Upholds NYSDEC's Finding That a Title V Renewal Application Was Consistent With the CLCPA